BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 30099376)

  • 1. Evolving Paradigms in HIV Malignancies: Review of Ongoing Clinical Trials.
    Bender Ignacio RA; Lin LL; Rajdev L; Chiao E
    J Natl Compr Canc Netw; 2018 Aug; 16(8):1018-1026. PubMed ID: 30099376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of non-AIDS-defining cancers on people living with HIV.
    Chiao EY; Coghill A; Kizub D; Fink V; Ndlovu N; Mazul A; Sigel K
    Lancet Oncol; 2021 Jun; 22(6):e240-e253. PubMed ID: 34087151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal monitoring strategies for guiding when to switch first-line antiretroviral therapy regimens for treatment failure in adults and adolescents living with HIV in low-resource settings.
    Chang LW; Harris J; Humphreys E
    Cochrane Database Syst Rev; 2010 Apr; (4):CD008494. PubMed ID: 20393969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remembering the forgotten child: the role of immune checkpoint inhibition in patients with human immunod eficiency virus and cancer.
    Adashek JJ; Junior PNA; Galanina N; Kurzrock R
    J Immunother Cancer; 2019 May; 7(1):130. PubMed ID: 31113482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interventions for the treatment of oral and oropharyngeal cancers: targeted therapy and immunotherapy.
    Chan KK; Glenny AM; Weldon JC; Furness S; Worthington HV; Wakeford H
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD010341. PubMed ID: 26625332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy in People With HIV and Cancer.
    Puronen CE; Ford ES; Uldrick TS
    Front Immunol; 2019; 10():2060. PubMed ID: 31555284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Managing Pharmacotherapy in People Living With HIV and Concomitant Malignancy.
    Olin JL; Klibanov O; Chan A; Spooner LM
    Ann Pharmacother; 2019 Aug; 53(8):812-832. PubMed ID: 30770025
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunotherapy of Lymphoma and Myeloma: Facts and Hopes.
    Pianko MJ; Moskowitz AJ; Lesokhin AM
    Clin Cancer Res; 2018 Mar; 24(5):1002-1010. PubMed ID: 28899972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer in the HIV-Infected Host: Epidemiology and Pathogenesis in the Antiretroviral Era.
    Brickman C; Palefsky JM
    Curr HIV/AIDS Rep; 2015 Dec; 12(4):388-96. PubMed ID: 26475669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignancies in HIV-Infected and AIDS Patients.
    Ji Y; Lu H
    Adv Exp Med Biol; 2017; 1018():167-179. PubMed ID: 29052137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic treatments for metastatic cutaneous melanoma.
    Pasquali S; Hadjinicolaou AV; Chiarion Sileni V; Rossi CR; Mocellin S
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD011123. PubMed ID: 29405038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of HIV/AIDS associated cancers with immunotherapy targeting PD-1/PD-L1 instead of chemotherapy.
    Kasi PM; Block MS; Ansell SM
    Med Hypotheses; 2016 Jan; 86():129-31. PubMed ID: 26559886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune checkpoint therapy in liver cancer.
    Xu F; Jin T; Zhu Y; Dai C
    J Exp Clin Cancer Res; 2018 May; 37(1):110. PubMed ID: 29843754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [HIV and cancer: Update 2020].
    Abbar B; Veyri M; Solas C; Poizot-Martin I; Spano JP
    Bull Cancer; 2020 Jan; 107(1):21-29. PubMed ID: 31980144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Evolving Role of Immune Checkpoint Inhibitors in Cancer Treatment.
    Pennock GK; Chow LQ
    Oncologist; 2015 Jul; 20(7):812-22. PubMed ID: 26069281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of biomarkers to predict response to immunotherapy in cancer: Volume I - pre-analytical and analytical validation.
    Masucci GV; Cesano A; Hawtin R; Janetzki S; Zhang J; Kirsch I; Dobbin KK; Alvarez J; Robbins PB; Selvan SR; Streicher HZ; Butterfield LH; Thurin M
    J Immunother Cancer; 2016; 4():76. PubMed ID: 27895917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted Therapies for the Treatment of Glioblastoma in Adults.
    Chuang DF; Lin X
    Curr Oncol Rep; 2019 May; 21(7):61. PubMed ID: 31102038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.